Notice of Suspension of Publication
Dear Authors, Reviewers, and Readers,
We would like to express our sincere gratitude for your continued support and interest in Infection Advances.
After careful consideration and internal discussion, we regret to inform you that Infection Advances will suspend publication effective May 1, 2026.
This decision has been made in light of operational considerations and ongoing restructuring within the publishing group. We understand that this announcement may cause inconvenience, and we sincerely apologise to all authors, reviewers, editorial board members, and readers who have supported the journal.
Regarding Submitted and Upcoming Manuscripts
-
1. Manuscripts under consideration
For manuscripts that have been submitted but not yet published, we will contact the corresponding authors before May 1 to assist with transferring the manuscripts to suitable alternative journals. The handling process will be managed to ensure continuity and minimal disruption.
-
2. New submissions
For manuscripts not yet submitted, we kindly recommend that authors consider other appropriate journals for their work.
-
3. Accepted manuscripts
All accepted manuscripts will be processed and published as scheduled. Articles that are in pre-publication stages will be made available online before May 1, 2026.
Data Archiving and Accessibility
All articles published in Infection Advances will remain permanently accessible via their DOIs and the journal's official website. These publications will continue to be indexed and available for citation.
We would like to once again express our heartfelt appreciation for your trust and support. We hope to have the opportunity to collaborate with you again in future initiatives.
Sincerely,
Infection Advances
April 22, 2026
TMR Publishing Group